Abstract

Background Living donor liver transplantation (LDLT) provides an alternative to deceased donor liver transplantation (DDLT) for patients with end-stage liver disease in the circumstance of scarcity of deceased grafts. However, the outcomes of LDLT remain controversial. Method A systematic review and meta-analysis were performed to compare the outcomes of LDLT with DDLT. Twelve outcomes were assessed. Results Thirty-nine studies involving 38563 patients were included. LDLT was comparable in red blood cell transfusion, perioperative mortality, length of hospital stay, retransplantation rate, hepatitis C virus recurrence rate, and hepatocellular carcinoma recurrence rate with DDLT. Cold ischemia time was shorter and duration of recipient operation was longer in LDLT. Postoperative intra-abdominal bleeding rate occurred less frequently in LDLT recipients (odds ratio (OR) = 0.64, 95%confidence interval (CI) = 0.46 − 0.88, P = 0.006), but this did not decrease the perioperative mortality. LDLT was associated with significantly higher biliary (OR = 2.23, 95%CI = 1.59 − 3.13, P < 0.00001) and vascular (OR = 2.00, 95%CI = 1.31 − 3.07, P = 0.001) complication rates and better overall survival (OS) (1 year: OR = 1.32, 95%CI = 1.01 − 1.72, P = 0.04; 3 years: OR = 1.39, 95%CI = 1.14 − 1.69, P = 0.0010; and 5 years: OR = 1.33, 95%CI = 1.04 − 1.70, P = 0.02). According to subgroup analysis, biliary complication rate and OS improved dramatically as experience increased, while vascular complication rate could not be improved because it was mainly caused by the difference of the donor type itself. Conclusions LDLT remains a valuable option for patients in need of liver transplantation for it provides an excellent alternative to DDLT without compromising recipient outcomes. Further refinement in biliary and vascular reconstruction techniques and the accumulation of liver transplantation centers' experience are the key factors in expanding the application of LDLT.

Highlights

  • Liver transplantation (LT) is a well-established therapeutic option for patients with irremediable end-stage liver disease

  • 10 studies were excluded after full text review for the following reasons: 2 studies were based on overlapping data from the same database, 5 studies lacked a control group, 1 study had no available data, 1 study focused on pediatric LT, and 1 study was about combined liver and kidney transplantation

  • Fifteen studies investigated patients with various liver diseases, 10 studies were about hepatitis B/C virus-related diseases, and 14 studies focused on hepatocellular carcinoma (HCC)

Read more

Summary

Introduction

Liver transplantation (LT) is a well-established therapeutic option for patients with irremediable end-stage liver disease. LDLT has been widely considered as an alternative to deceased donor liver transplantation (DDLT). Lots of studies comparing the clinical outcomes of LDLT with DDLT were carried out in the past decades, the issues remained for the inconformity of conclusions. With the aim of comparing the outcomes of LDLT with DDLT, we systematically summarized the current available data and performed a meta-analysis. Living donor liver transplantation (LDLT) provides an alternative to deceased donor liver transplantation (DDLT) for patients with end-stage liver disease in the circumstance of scarcity of deceased grafts. A systematic review and meta-analysis were performed to compare the outcomes of LDLT with DDLT. LDLT remains a valuable option for patients in need of liver transplantation for it provides an excellent alternative to DDLT without compromising recipient outcomes. Further refinement in biliary and vascular reconstruction techniques and the accumulation of liver transplantation centers’ experience are the key factors in expanding the application of LDLT

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call